LSM4, with a hazard ratio of 3.09 (95%CI, 1.35–4.48), was the most significant among the “harmful genes.” Furthermore, Kaplan–Meier survival curves for the four LSM genes were compared for 123 patients with MCL using the log-rank test (Fig. 2; LSM8, P = 1.7E-02; LSM2, P = 4.6E-03; LSM1, P = 4.5E-03; LSM4, P = 1.6E-05, log-rank test). This evidence concerns the gene LSM2 and mantle cell lymphoma.